BackPluristem Therapeutics Overview

Pluristem Therapeutics Profit Margin

Profitability ratio analysis for PSTI.

Quarterly Profit Margin

-3695.81%
↓ 149.11% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-870.11%
↑ 71.10% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin